We provide you with 20 years of free, institutional-grade data for CRON stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CRON. Explore the full financial landscape of CRON stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Weigensberg Arye | Initial | 2022-08-18 | |||
| Gorelik Ran | Initial | 2022-04-28 | |||
| Doucet Terrence Gregory Joseph | Initial | 2022-04-28 |
The information provided in this report about CRON stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cronos Group Inc(NASDAQ:CRON) 
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in...
Website: http://www.thecronosgroup.com
Founded: 2012
Full Time Employees: 631
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic